Evidence map›Paper›PMID 18483557›Full record

ArticlePLoS genetics2008

HOXA13 Is essential for placental vascular patterning and labyrinth endothelial specification.

Carley A E Shaut, Douglas R Keene, Lise K Sorensen, Dean Y Li, H Scott Stadler

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 100 citations in OpenAlex.

  1. Article
  2. Feto-placental blood vessel development.Development (Cambridge, England) · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Carley A E ShautDepartment of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon, United States of America.
Douglas R Keene
Lise K Sorensen
Dean Y Li
H Scott Stadler
Shriners Hospitals for Children - Portland · USUniversity of Utah · USOregon Health & Science University · US

Funding

Transcriptional regulation of bladder-ureter developmentR01DK066539 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI STADLER, H. SCOTT · 2004 to 2007
$1.2M
NIDDK NIH HHS R01 DK066539NIDDK NIH HHS R01 DK66539
6 · The paper itself

Abstract

In eutherian mammals, embryonic growth and survival is dependent on the formation of the placenta, an organ that facilitates the efficient exchange of oxygen, nutrients, and metabolic waste between the maternal and fetal blood supplies. Key to the placenta's function is the formation of its vascular labyrinth, a series of finely branched vessels whose molecular ontogeny remains largely undefined. In this report, we demonstrate that HOXA13 plays an essential role in labyrinth vessel formation. In the absence of HOXA13 function, placental endothelial cell morphology is altered, causing a loss in vessel wall integrity, edema of the embryonic blood vessels, and mid-gestational lethality. Microarray analysis of wild-type and mutant placentas revealed significant changes in endothelial gene expression profiles. Notably, pro-vascular genes, including Tie2 and Foxf1, exhibited reduced expression in the mutant endothelia, which also exhibited elevated expression of genes normally expressed in lymphatic or sinusoidal endothelia. ChIP analysis of HOXA13-DNA complexes in the placenta confirmed that HOXA13 binds the Tie2 and Foxf1 promoters in vivo. In vitro, HOXA13 binds sequences present in the Tie2 and Foxf1 promoters with high affinity (K(d) = 27-42 nM) and HOXA13 can use these bound promoter regions to direct gene expression. Taken together, these findings demonstrate that HOXA13 directly regulates Tie2 and Foxf1 in the placental labyrinth endothelia, providing a functional explanation for the mid-gestational lethality exhibited by Hoxa13 mutant embryos as well as a novel transcriptional program necessary for the specification of the labyrinth vascular endothelia.

Indexed as

Gene Expression Regulation, DevelopmentalAnimalsBase SequenceEndothelium, VascularForkhead Transcription FactorsGenes, ReporterHomeodomain ProteinsHomozygoteIn Vitro TechniquesMiceMice, KnockoutMolecular Sequence DataNeovascularization, PhysiologicOligonucleotide Array Sequence AnalysisPlacentaPromoter Regions, GeneticForkhead Transcription FactorsFoxf1 protein, mousehomeobox protein HOXA13Homeodomain ProteinsReceptor, TIE-2

Identifiers

PMID18483557
PMCPMC2367452
OpenAlexW1982434780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.